The $21 Billion Nasdaq Price on Kraken Isn't About Kraken's Earnings

Nasdaq is putting $100 million into Payward, the company behind crypto exchange Kraken, at a valuation of $21 billion. Read as a headline, it sounds like one exchange buying into another on the strength of crypto's comeback. The detail that should give a careful reader pause is different: Payward just reported about $23 million in adjusted pre-tax profit for its latest quarter, down 71% from a year earlier. Nobody pays $21 billion for that. The useful question is what the money is actually buying.

Two prices for the same company in five months

Start with the pricing history, because it reveals the deal. Payward was worth $15 billion after a funding round in September 2025, then $20 billion in a late-2025 raise led partly by market maker Citadel Securities. When crypto markets stumbled this spring, private investors marked it down to $13.3 billion in April, when Deutsche Börse put in $200 million. Now Nasdaq's venture arm has paid at a $21 billion valuation — roughly 58% higher than the April mark, five months later, for a company whose disclosed profits were collapsing even as its revenue grew.

Nothing in Payward's cash flow explains that swing. The rebound is a strategic investor pricing an opportunity that a financial holder was not paying for. Nasdaq is not buying Kraken's trading fees. It is buying a seat in the race to tokenize American stocks.

The game being played

Since March of this year, the two companies have been designing a "stock conversion gateway" that lets tokenized shares move between regulated markets and blockchains. Kraken's retail platform would distribute Nasdaq-approved tokenized stocks, and customers holding them keep the same voting rights and corporate actions as ordinary shareholders. Payward would serve as the primary settlement layer. Federal regulators cleared the path: the SEC, under Chairman Paul Atkins, approved Nasdaq's rule change for trading tokenized stocks in March, and approved a similar framework for the New York Stock Exchange in April. Nasdaq plans to bring its stock-token design live in the first half of 2027.

This is the 24-hour-trading race, and Kraken is Nasdaq's on-ramp to it. Nasdaq brings the regulated exchange, the issuer relationships, and the legal machinery that keeps tokenized shares legally equivalent to ordinary ones. Kraken brings roughly 6.1 million funded customer accounts and proof of concept: its own tokenized US stocks, offered under the xStocks label, have already passed $5 billion in cumulative trading volume. Each side is selling the other the half it lacks.

That is the kind of arrangement where the durable economics are genuinely unclear. Nasdaq needs retail distribution for its tokenized listings, and Kraken is one channel among several — the NYSE is building its own blockchain-based venue for 24/7 trading of tokenized stocks and ETFs. Payward, in turn, already distributes stocks through its own xStocks product, so the Nasdaq deal is one more rail rather than the only one. A control point only matters if it changes adoption or capture. Right now the tokenized-stock market is too new to say who ends up keeping the recurring fees, and whether the users who arrive are customers who stay or volume that needed a push.

The price is for an option

That uncertainty is worth holding onto when judging the $21 billion. Payward's financials tell a story of a company borrowing scale and legitimacy rather than compounding from its trading business. Revenue did reach $2.2 billion last year, but adjusted EBITDA fell from $530 million for all of 2025 to just $18 million in the first quarter of 2026, as Payward spent through a roughly $2.65 billion acquisition spree — futures broker NinjaTrader for $1.5 billion, derivatives platform Bitnomial for up to $550 million, and stablecoin-payments firm Reap for up to $600 million. That is a super-app strategy: build one account through which a customer trades crypto, stocks, derivatives, and pays, and hope the cross-selling lifts per-user revenue. It is expensive, unproven on profit, and it is why a skeptical reader should treat the $21 billion as the price of a strategic option rather than evidence that the strategy already works.

What does that mean for an ordinary investor? The direct exposure is thin. Payward is private, and its IPO has slipped from a late-2025 confidential filing into 2027, so there is no clean way to own this specific bet yet. The read-through runs to the public names in the trade. For Nasdaq investors, the $100 million is a rounding error against a company of that scale — this matters for strategy, not for this quarter's numbers, and it will earn its keep only if tokenized listings and settlement become a real, recurring revenue line over years. For Coinbase holders, the deal is a reminder that distribution of tokenized equities is becoming contested, and that Nasdaq is choosing a crypto-native partner. And for anyone watching the theme itself, the honest boundary is this: a strategic investor marking Kraken back up to $21 billion tells you where the industry's gatekeepers think value will accumulate, not that value is already there. The economics of who actually keeps the money are still being written.